- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT04208724
Support Program for Adoption of Cancer Screening Interventions at a Rural Community-Based Organization
Implementation Studio, an Innovative, Structured Approach to Facilitate Rural Community-Based Organizations' Adaptation and Implementation of Evidence-Based Interventions
Studieoversikt
Status
Intervensjon / Behandling
Detaljert beskrivelse
OUTLINE:
Community-based organizations participate in the support program, consisting of 2 half-day training workshops over 2 weeks, and 30-minute bi-weekly consultations in order to adapt and implement the cancer screening intervention for community members.
After completion of study, participants are followed up at 3 months.
Studietype
Registrering (Faktiske)
Fase
- Ikke aktuelt
Kontakter og plasseringer
Studiesteder
-
-
Washington
-
Seattle, Washington, Forente stater, 98109
- Fred Hutch/University of Washington Cancer Consortium
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Beskrivelse
Inclusion Criteria:
- Objective II COMMUNITY-BASED ORGANIZATION: Located in the Yakima Valley of Washington State
- Objective II COMMUNITY-BASED ORGANIZATION: Serve community members who are 18 and older
- Objective II COMMUNITY-BASED ORGANIZATION: Willing to commit to the 6-month program
- Objective II PARTICIPANTS: Receiving services from the recruited community-based organization
Objective III PARTICIPANTS: Not up-to-date for breast, cervical, and colorectal cancer screening according to current U.S. Preventive Services Tasks Force (USPSTF) guidelines. The current USPSTF recommendations for breast, cervical, and colorectal cancer are:
- Breast Cancer Screening: Women ages 50-74 should be screened for breast cancer with mammography every 2 years.
- Cervical Cancer Screening: Women ages 21-29 should be screened for cervical cancer every 3 years with cervical cancer cytology alone. For women ages 30-65, the USPSTF recommends screening every 3 years with cervical cytology alone, every 5 years or every 5 years with high risk human papillomavirus (hrHPV) testing in combination of cytology.
- Colorectal Cancer Screening: Individuals ages 50-75 should be screened for colorectal cancer with guaiac-based fecal occult blood tests (gFOBT) or fecal immunochemical test (FIT) once a year, or colonoscopy every 10 years (USPSTF approves additional screening tests, but these are the most commonly used).
- Objective III PARTICIPANTS: If the community-based organization selects breast cancer screening, we will recruit women ages 50-74.
- Objective III PARTICIPANTS: If the community-based organization selects cervical cancer screening, we will recruit women ages 21-65.
- Objective III PARTICIPANTS: If the community-based organization selects colorectal cancer screening, we will recruit women and men ages 50-75.
- Objective III PARTICIPANTS: Average risk for breast, cervical, or colorectal cancer
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Helsetjenesteforskning
- Tildeling: N/A
- Intervensjonsmodell: Enkeltgruppeoppdrag
- Masking: Ingen (Open Label)
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
---|---|
Eksperimentell: Training program
Community-based organizations participate in the support program, consisting of 2 half-day training workshops over 2 weeks, and 30-minute bi-weekly consultations in order to adapt and implement the cancer screening intervention for community members.
|
Hjelpestudier
Participate in the training program
Andre navn:
Receive cancer screening intervention
Andre navn:
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
---|---|---|
Develop the structural program
Tidsramme: 3 months
|
Development of the structural training program and accompanying tools
|
3 months
|
Implementation Monitoring
Tidsramme: 4 months
|
Implementation of the evidence-based intervention by the community-based organization including 1) dosage (how many interventions were delivered to the participants), 2) types (for which cancer), 3) length of exposure (for how long), and 4) who is involved in the implementation (by whom).
|
4 months
|
Intention to get screened for cancer (type of cancer will be determined by the community-based organization) pre- and post-intervention
Tidsramme: Up to 3 months
|
Difference in the proportion of intention to get screened for cancer pre- and post-intervention using chi-square analyses
|
Up to 3 months
|
Samarbeidspartnere og etterforskere
Sponsor
Studierekorddatoer
Studer hoveddatoer
Studiestart (Faktiske)
Primær fullføring (Faktiske)
Studiet fullført (Faktiske)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Faktiske)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Ytterligere relevante MeSH-vilkår
- Sykdommer i fordøyelsessystemet
- Hudsykdommer
- Neoplasmer etter histologisk type
- Neoplasmer
- Neoplasmer etter nettsted
- Neoplasmer, kjertel og epitel
- Gastrointestinale neoplasmer
- Neoplasmer i fordøyelsessystemet
- Gastrointestinale sykdommer
- Bryst sykdommer
- Kolonsykdommer
- Tarmsykdommer
- Intestinale neoplasmer
- Rektale sykdommer
- Brystneoplasmer
- Karsinom
- Kolorektale neoplasmer
Andre studie-ID-numre
- RG1006143
- NCI-2019-08033 (Registeridentifikator: NCI / CTRP)
- 10307 (Annen identifikator: Fred Hutch/University of Washington Cancer Consortium)
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Studerer et amerikansk FDA-regulert enhetsprodukt
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .
Kliniske studier på Ondartet fast neoplasma
-
Guangzhou First People's HospitalFullført
-
Shenzhen Ionova Life Sciences Co., Ltd.Merck Sharp & Dohme LLCRekrutteringKreft | Solid svulst, voksen | Solid karsinom | Solid svulst, uspesifisert, voksen | Kreft Metastatisk | Svulst, solidForente stater
-
Albert Einstein College of MedicineAvsluttetKreft | Solid svulst | Metastatisk solid svulst | Metastatisk dMMR solid kreftForente stater
-
Memorial Sloan Kettering Cancer CenterRekrutteringSolid svulst | Solid svulst, voksen | Solid svulst, uspesifisert, voksenForente stater
-
Memorial Sloan Kettering Cancer CenterLincoln Medical and Mental Health CenterRekrutteringSolid svulst | Solid svulst, voksen | Solid svulst, uspesifisert, voksenForente stater, Puerto Rico
-
Memorial Sloan Kettering Cancer CenterLincoln Medical and Mental Health CenterRekrutteringSolid svulst | Solid svulst, voksen | Solid svulst, uspesifisert, voksenForente stater, Puerto Rico
-
Impact Therapeutics, Inc.RekrutteringSolid svulst | Avansert solid svulstKina, Taiwan, Forente stater, Australia
-
Partner Therapeutics, Inc.TilbaketrukketSolid svulst | Solid svulst, voksenForente stater
-
RemeGen Co., Ltd.FullførtMetastatisk solid svulst | Lokalt avansert solid svulst | Ikke-opererbar solid svulstAustralia
-
BeiGeneRekrutteringSolid svulst | Avansert solid svulstForente stater, New Zealand, Australia, Kina
Kliniske studier på Undersøkelsesadministrasjon
-
Yale UniversityNational Institute on Drug Abuse (NIDA); APT Foundation, Inc.FullførtTobakksbruk | Sigarett røykingForente stater
-
Pennington Biomedical Research CenterCorby K. MartinRekrutteringErnæringsvitenskap | Klima | Resirkulering | AvfallshåndteringForente stater
-
George Washington UniversityFullført
-
University of NottinghamKing's College London; National Institute for Health Research, United KingdomRekrutteringFibrose | Artroplastikkkomplikasjoner | Kontraktur av kneleddStorbritannia
-
Cairn DiagnosticsFullført
-
Ceribell Inc.FullførtAnfall | Ikke-konvulsiv Status EpilepticusForente stater
-
Boston Medical CenterNational Heart, Lung, and Blood Institute (NHLBI)Fullført
-
PATHMinistry of Health, Zambia; AKROS Global HealthFullført
-
Gruppo Italiano Malattie EMatologiche dell'AdultoFullført
-
Jagiellonian UniversityRekruttering